Frank G Keller
5PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 09, 2026
Three-Year Follow-Up of Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Adolescents With Advanced-Stage Classic Hodgkin Lymphoma on S1826.Sharon M Castellino, Hongli Li, Alex F Herrera
|Sep 24, 2025
Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma.Keri Toner, Lindsay A Renfro, Hema Dave
|Sep 20, 2024
Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma.Mallorie B Heneghan, Susan K Parsons, Frank G Keller
|Jul 26, 2024
Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study.AnnaLynn M Williams, Angie Mae Rodday, Qinglin Pei
|May 29, 2024
Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-risk Classical Hodgkin Lymphoma.Zufei Zhang, Daping Zhang, Wenchuan Guo
Pageof 1
Frequent Collaborators
4 joint publications
Kara M Kelly
3 joint publications
Susan K Parsons
2 joint publications
Sharon M Castellino
2 joint publications
Tara O Henderson
1 joint publications
Joo Y Song
1 joint publications
Daping Zhang
1 joint publications
Wenchuan Guo
1 joint publications
Keenan Fenton
1 joint publications
Sujata Narayanan
1 joint publications
Shweta Jain
